[
    {
        "question_id": "5478_B_2",
        "new_question_id": "16463",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "4537",
        "notes_id_link": "1_2155",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Right third cranial nerve (CN3) palsy",
            "Left sixth cranial nerve (CN6) palsy",
            "Right sixth cranial nerve (CN6) palsy",
            "Left fourth cranial nerve (CN4) palsy",
            "Left third cranial nerve (CN3) palsy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 78-year-old man presented to the eye casualty with diplopia. He has been noticing this double vision for the past two weeks. On examination, there was horizontal diplopia and minimal restriction of one of the extraocular muscles in the left eye. His past medical history includes longstanding prostate cancer and hypertension. Imaging of the brain revealed metastatic lesion in the clivus encasing the cavernous sinus and carotid artery.<br /><br />Which one of the following cranial nerve palsy leads to diplopia in this patient?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "The sixth cranial nerve (CN6) innervates the lateral rectus muscle which is responsible for moving the eye laterally. CN6 arises from the pons which sits on the clivus. Hence, a tumour involving the clivus would compress the CN6 causing its palsy. This leads to restricted lateral gaze which results in horizontal diplopia as seen in this patient. Right cranial nerve palsies are irrelevant as the question clearly states the involvement of left extraocular muscle. CN4 palsy causes vertical diplopia. CN3 palsy causes ptosis and involves four extraocular muscles rather than one that is mentioned in the question.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 78-year-old man presented to the eye casualty with diplopia. He has been noticing this double vision for the past two weeks. On examination, there was horizontal diplopia and minimal restriction of one of the extraocular muscles in the left eye. His past medical history includes longstanding prostate cancer and hypertension. Imaging of the brain revealed metastatic lesion in the clivus encasing the cavernous sinus and carotid artery.<br /><br />Which one of the following cranial nerve palsy leads to diplopia in this patient?",
        "correct_answer": "2",
        "question_notes": "The sixth cranial nerve (CN6) innervates the lateral rectus muscle which is responsible for moving the eye laterally. CN6 arises from the pons which sits on the clivus. Hence, a tumour involving the clivus would compress the CN6 causing its palsy. This leads to restricted lateral gaze which results in horizontal diplopia as seen in this patient. Right cranial nerve palsies are irrelevant as the question clearly states the involvement of left extraocular muscle. CN4 palsy causes vertical diplopia. CN3 palsy causes ptosis and involves four extraocular muscles rather than one that is mentioned in the question.",
        "answer_order": "2",
        "answer": "2",
        "title": "Cranial nerves",
        "body": "The table below lists the major characteristics of the 12 cranial nerves:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Nerve</b></th><th><b>Functions</b></th><th><b>Clinical</b></th><th><b>Pathway/foramen</b></th></tr></thead><tbody><tr><td>I (Olfactory)</td><td>Smell</td><td></td><td>Cribriform plate</td></tr><tr><td>II (Optic)</td><td>Sight</td><td></td><td>Optic canal</td></tr><tr><td>III (Oculomotor)</td><td>Eye movement (MR, IO, SR, IR)<br />Pupil constriction<br />Accomodation<br />Eyelid opening</td><td>Palsy results in<br /><ul><li>ptosis</li><li>'down and out' eye</li><li>dilated, fixed pupil</td><td>Superior orbital fissure (SOF)</td></tr><tr><td></li></ul>IV (Trochlear)</td><td>Eye movement (SO)</td><td>Palsy results in defective downward gaze &rarr; vertical diplopia</td><td>SOF</td></tr><tr><td>V (Trigeminal)</td><td>Facial sensation<br />Mastication</td><td>Lesions may cause:<br /><ul><li>trigeminal neuralgia</li><li>loss of corneal reflex (afferent)</li><li>loss of facial sensation</li><li>paralysis of mastication muscles</li><li>deviation of jaw to weak side</td><td>V<sub>1</sub>: SOF,  </li></ul>V<sub>2</sub>: Foramen rotundum, <br />V<sub>3</sub>: Foramen ovale</td></tr><tr><td>VI (Abducens)</td><td>Eye movement (LR)</td><td>Palsy results in defective abduction &rarr; horizontal diplopia</td><td>SOF</td></tr><tr><td>VII (Facial)</td><td>Facial movement<br />Taste (anterior 2/3rds of tongue)<br />Lacrimation<br />Salivation</td><td>Lesions may result in:<br /><ul><li>flaccid paralysis of upper + lower face</li><li>loss of corneal reflex (efferent)</li><li>loss of taste</li><li>hyperacusis</td><td>Internal auditory meatus</td></tr><tr><td></li></ul>VIII (Vestibulocochlear)</td><td>Hearing, balance</td><td>Hearing loss<br />Vertigo, nystagmus<br />Acoustic neuromas are Schwann cell tumours of the cochlear nerve</td><td>Internal auditory meatus</td></tr><tr><td>IX (Glossopharyngeal)</td><td>Taste (posterior 1/3rd of tongue)<br />Salivation<br />Swallowing <br />Mediates input from carotid body & sinus</td><td>Lesions may result in;<br /><ul><li>hypersensitive carotid sinus reflex</li><li>loss of gag reflex (afferent)</td><td>Jugular foramen</td></tr><tr><td></li></ul>X (Vagus)</td><td>Phonation<br />Swallowing<br />Innervates viscera</td><td>Lesions may result in;<br /><ul><li>uvula deviates away from site of lesion</li><li>loss of gag reflex (efferent)</td><td>Jugular foramen</td></tr><tr><td></li></ul>XI (Accessory)</td><td>Head and shoulder movement</td><td>Lesions may result in;<br /><ul><li>weakness turning head to contralateral side</td><td>Jugular foramen</td></tr><tr><td></li></ul>XII (Hypoglossal)</td><td>Tongue movement</td><td>Tongue deviates towards side of lesion</td><td>Hypoglossal canal</td></tr></tbody></table></div><br />Some cranial nerves are motor, some sensory and some are both. The most useful mnemonic is given below.<br /><br /><div class='alert alert-warning'>CN I ----------------------------------------------------------------------&rarr;XII<br /><br /><b>S</b>ome <b>S</b>ay <b>M</b>arry <b>M</b>oney <b>B</b>ut <b>M</b>y <b>B</b>rother <b>S</b>ays <b>B</b>ig <b>B</b>rains <b>M</b>atter <b>M</b>ost<br /><br /><b>S</b> = Sensory, <b>M</b> = Motor, <b>B</b> = Both<br /></div><br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb018b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb018.png'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>Image sourced from </span><a href='https://en.wikipedia.org/wiki/Main_Page'  target='_blank' style = 'font-size:11px; color:LightGray;' >Wikipedia</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb018b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>View from the inferior surface of the brain showing the emergence of the cranial nerves<br /></div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb019b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb019.png'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>Image sourced from </span><a href='https://en.wikipedia.org/wiki/Main_Page'  target='_blank' style = 'font-size:11px; color:LightGray;' >Wikipedia</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb019b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the nuclei of the cranial nerves in the brainstem<br /></div><br /><br /><h5 class='notes-heading'>Cranial nerve reflexes</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Reflex</b></th><th><b>Afferent limb</b></th><th><b>Efferent limb</b></th></tr></thead><tbody><tr><td>Corneal</td><td>Ophthalmic nerve (V<sub>1</sub>)</td><td>Facial nerve (VII)</td></tr><tr><td>Jaw jerk</td><td>Mandibular nerve (V<sub>3</sub>)</td><td>Mandibular nerve (V<sub>3</sub>)</td></tr><tr><td>Gag</td><td>Glossopharyngeal nerve (IX)</td><td>Vagal nerve (X)</td></tr><tr><td>Carotid sinus</td><td>Glossopharyngeal nerve (IX)</td><td>Vagal nerve (X)</td></tr><tr><td>Pupillary light</td><td>Optic nerve (II)</td><td>Oculomotor nerve (III)</td></tr><tr><td>Lacrimation</td><td>Ophthalmic nerve (V<sub>1</sub>)</td><td>Facial nerve (VII)</td></tr></tbody></table></div>",
        "notes_hash": "d9943d3af49e44def8021b1bb2b22074",
        "knowledge_graph_node_id_link": 0,
        "concept": "CN6 palsy manifesting as diplopia could be the first sign of brain metastasis ",
        "concept_percentile": "74",
        "concept_colour": "rgb(132,255,0)",
        "number_attempts": "5737",
        "up_votes": "60",
        "down_votes": "64",
        "column_array": [
            0,
            "537",
            "2869",
            "651",
            "614",
            "1066",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Pl2ozPSWfHs\" data-description=\"Sixth Cranial Nerve Palsy\" data-upvotes=\"16\" data-downvotes=\"0\" data-media=\"225\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Pl2ozPSWfHs/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Pl2ozPSWfHs\" data-description=\"Sixth Cranial Nerve Palsy\" data-upvotes=\"16\" data-downvotes=\"0\" data-media=\"225\">Sixth Cranial Nerve Palsy</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_371\" data-mediaid=\"371\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_371\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"media_dislike_371\" data-mediaid=\"371\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_371\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/AEL0xeJ_NSw\" data-description=\"Third Cranial Nerve Palsy\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"222\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/AEL0xeJ_NSw/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/AEL0xeJ_NSw\" data-description=\"Third Cranial Nerve Palsy\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"222\">Third Cranial Nerve Palsy</a></td></tr><tr><td><span ><small>U-M Kellogg Eye Center - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_370\" data-mediaid=\"370\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_370\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_370\" data-mediaid=\"370\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_370\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/OZvIk76cSAI\" data-description=\"2-Minute Neuroscience: Vestibulocochlear Nerve (Cranial Nerve VIII)\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"950\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/OZvIk76cSAI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/OZvIk76cSAI\" data-description=\"2-Minute Neuroscience: Vestibulocochlear Nerve (Cranial Nerve VIII)\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"950\">2-Minute Neuroscience: Vestibulocochlear Nerve (Cranial Nerve VIII)</a></td></tr><tr><td><span ><small>Neuroscientifically Challenged - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1646\" data-mediaid=\"1646\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1646\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1646\" data-mediaid=\"1646\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1646\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wkzyVO4-gmE\" data-description=\"2-Minute Neuroscience: Abducens Nerve (Cranial Nerve VI)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"948\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/wkzyVO4-gmE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wkzyVO4-gmE\" data-description=\"2-Minute Neuroscience: Abducens Nerve (Cranial Nerve VI)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"948\">2-Minute Neuroscience: Abducens Nerve (Cranial Nerve VI)</a></td></tr><tr><td><span ><small>Neuroscientifically Challenged - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1644\" data-mediaid=\"1644\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1644\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1644\" data-mediaid=\"1644\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1644\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Kmx8ZYqhGIo\" data-description=\"2-Minute Neuroscience: Glossopharyngeal Nerve (Cranial Nerve IX)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"947\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Kmx8ZYqhGIo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Kmx8ZYqhGIo\" data-description=\"2-Minute Neuroscience: Glossopharyngeal Nerve (Cranial Nerve IX)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"947\">2-Minute Neuroscience: Glossopharyngeal Nerve (Cranial Nerve IX)</a></td></tr><tr><td><span ><small>Neuroscientifically Challenged - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1643\" data-mediaid=\"1643\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1643\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1643\" data-mediaid=\"1643\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1643\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hDbWV0EZCAU\" data-description=\"Cranial Nerves Anatomy\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"281\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hDbWV0EZCAU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hDbWV0EZCAU\" data-description=\"Cranial Nerves Anatomy\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"281\">Cranial Nerves Anatomy</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_482\" data-mediaid=\"482\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_482\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_482\" data-mediaid=\"482\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_482\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/i8OHZ8t6vg0\" data-description=\"Cranial nerve anatomy\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"105\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/i8OHZ8t6vg0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/i8OHZ8t6vg0\" data-description=\"Cranial nerve anatomy\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"105\">Cranial nerve anatomy</a></td></tr><tr><td><span ><small>e-channel - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_184\" data-mediaid=\"184\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_184\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_184\" data-mediaid=\"184\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_184\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/AMAR-hv7knI\" data-description=\"The Facial Nerve (CNVII): Animated Review\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"466\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/AMAR-hv7knI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/AMAR-hv7knI\" data-description=\"The Facial Nerve (CNVII): Animated Review\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"466\">The Facial Nerve (CNVII): Animated Review</a></td></tr><tr><td><span ><small>FSUMedMedia - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_817\" data-mediaid=\"817\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_817\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_817\" data-mediaid=\"817\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_817\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 12,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "6043_B_31",
        "new_question_id": "33259",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "4659",
        "notes_id_link": "1_2726",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Reassure him that his hearing loss will settle by itself within a few days",
            "Refer to audiology",
            "Routine outpatient referral to ENT",
            "Urgent outpatient referral to ENT",
            "Same-day referral to ENT",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 50-year-old accountant sees his GP complaining of sudden deafness in his left ear the day before. This happened whilst he was loading the dishwasher at home. <br /><br />He has previously had ear irrigation in both ears for impacted cerumen and has continued with his GP's advice of regular olive oil drops. He is otherwise fit and well, and denies any trauma to his head or ears. He denies any tinnitus or vertigo.<br /><br />On examination, otoscopy is unremarkable in either ear. His cranial nerve examination is normal. Rinne's and Weber's tests suggest a sensorineural hearing loss in his left ear.<br /><br />What is the most appropriate management plan?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "This man has had acute sensorineural hearing loss. <b> This is an ENT emergency </b> and he needs to be seen by them within 24 hours; there is no clear external or middle ear cause, and his hearing loss has developed within the last thirty days. Same-day referral is therefore the correct answer.<br /><br />He will likely undergo an audiology assessment and brain MRI; this is to assess for tumours and other suspect causes. High dose steroids are often used in acute sensorineural hearing loss, even if the cause has not been identified.<br /><br />It would be <b>inappropriate</b> to reassure him given the cause of his deafness may be emergent and require rapid treatment.<br /><br /><b>Audiology referral</b> alone at this stage would be inappropriate, but may be appropriate for someone presenting with gradual hearing loss.<br /><br /><b>Outpatient referral to ENT</b>, routine or urgent, may be appropriate if the sudden-onset sensorineural hearing loss had developed more than 30 days ago and could not be explained by external or middle ear causes. The acuity of the presentation means a same-day referral is more appropriate.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 50-year-old accountant sees his GP complaining of sudden deafness in his left ear the day before. This happened whilst he was loading the dishwasher at home. <br /><br />He has previously had ear irrigation in both ears for impacted cerumen and has continued with his GP's advice of regular olive oil drops. He is otherwise fit and well, and denies any trauma to his head or ears. He denies any tinnitus or vertigo.<br /><br />On examination, otoscopy is unremarkable in either ear. His cranial nerve examination is normal. Rinne's and Weber's tests suggest a sensorineural hearing loss in his left ear.<br /><br />What is the most appropriate management plan?",
        "correct_answer": "5",
        "question_notes": "This man has had acute sensorineural hearing loss. <b> This is an ENT emergency </b> and he needs to be seen by them within 24 hours; there is no clear external or middle ear cause, and his hearing loss has developed within the last thirty days. Same-day referral is therefore the correct answer.<br /><br />He will likely undergo an audiology assessment and brain MRI; this is to assess for tumours and other suspect causes. High dose steroids are often used in acute sensorineural hearing loss, even if the cause has not been identified.<br /><br />It would be <b>inappropriate</b> to reassure him given the cause of his deafness may be emergent and require rapid treatment.<br /><br /><b>Audiology referral</b> alone at this stage would be inappropriate, but may be appropriate for someone presenting with gradual hearing loss.<br /><br /><b>Outpatient referral to ENT</b>, routine or urgent, may be appropriate if the sudden-onset sensorineural hearing loss had developed more than 30 days ago and could not be explained by external or middle ear causes. The acuity of the presentation means a same-day referral is more appropriate.",
        "answer_order": "5",
        "answer": "5",
        "title": "Sudden-onset sensorineural hearing loss",
        "body": "When a patient presents with sudden onset hearing loss it is important to examine them carefully to differentiate between conductive and sensorineural hearing loss &rarr; sudden-onset sensorineural hearing loss (SSNHL) requires <span class=\"concept\" data-cid=\"4659\">urgent referral to ENT</span>.<br /><br />The majority of SSNHL cases are <span class=\"concept\" data-cid=\"10937\">idiopathic</span>.<br /><br />An MRI scan is usually performed to exclude a vestibular schwannoma.<br /><br />High-dose <span class=\"concept\" data-cid=\"10938\">oral corticosteroids</span> are used by ENT for all cases of SSNHL.",
        "notes_hash": "c58e17a65451e6b07df07d66ae7cafea",
        "knowledge_graph_node_id_link": 11059,
        "concept": "Acute sensorineural hearing loss is an emergency and requires urgent referral to ENT for audiology assessment and brain MRI",
        "concept_percentile": "52",
        "concept_colour": "rgb(244,255,0)",
        "number_attempts": "5656",
        "up_votes": "44",
        "down_votes": "108",
        "column_array": [
            0,
            "98",
            "207",
            "115",
            "2282",
            "2954",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1997\" data-linkid=\"1997\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1997\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1997\" data-linkid=\"1997\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1997\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng98/chapter/recommendations\">2018 Hearing loss in adults: assessment and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_kUy4p87_nk\" data-description=\"Understanding the Causes of Hearing Loss\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"1447\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/_kUy4p87_nk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_kUy4p87_nk\" data-description=\"Understanding the Causes of Hearing Loss\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"1447\">Understanding the Causes of Hearing Loss</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2558\" data-mediaid=\"2558\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2558\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_2558\" data-mediaid=\"2558\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2558\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 9,
        "concepts_for_notes": {
            "4659": {
                "concept_text": "Acute sensorineural hearing loss is an emergency and requires urgent referral to ENT for audiology assessment and brain MRI",
                "concept_percentile": "52"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1667",
        "new_question_id": "3705",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_1635",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Trigeminal neuralgia",
            "Temporomandibular joint dysfunction",
            "Temporal arteritis",
            "Cluster headache",
            "Herpes zoster ophthalmicus",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 61-year-old man presents with a two-week history of a sharp, stabbing pain over his right cheekbone. He describes the pain as 'very severe' and 'coming in spasms'. It typical lasts for around one minute before subsiding. The pain can be triggered by shaving and eating. Examination of his eyes, cranial nerves and mouth is unremarkable. What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The most likely diagnosis for this patient is <b>Trigeminal neuralgia</b>. Trigeminal neuralgia, also known as tic douloureux, is a severe facial pain disorder that affects the trigeminal or 5th cranial nerve. The symptoms described by the patient - sharp, stabbing pain over the cheekbone area that comes in spasms and can be triggered by routine activities such as shaving and eating - are characteristic of this condition. The pain typically lasts from a few seconds to several minutes.<br /><br /><b>Temporomandibular joint dysfunction</b> presents with symptoms such as difficulty opening the mouth wide, jaw clicking or popping sounds, earache, headache and facial ache. However, it does not typically cause sharp, stabbing pains that come in spasms and are triggered by routine activities like shaving or eating.<br /><br /><b>Temporal arteritis</b>, also known as giant cell arteritis, is an inflammation of the arteries in and around the scalp. This condition usually presents with new onset headache, scalp tenderness (especially over the temporal arteries), jaw claudication (pain with chewing) and visual disturbances. It doesn't align well with this patient's presentation.<br /><br />A <b>Cluster headache</b> is another type of primary headache disorder but its pain is usually located around one eye (periorbital) or on one side of the head. It's often accompanied by autonomic symptoms like tearing, nasal congestion or pupil changes on the same side of the headache which were not reported by this patient.<br /><br /><b>Herpes zoster ophthalmicus</b> involves the reactivation of varicella-zoster virus within the first division of the trigeminal nerve. It would present with a painful rash in a dermatomal distribution involving the forehead and potentially the eye along with other ocular symptoms if eye involvement occurs. This does not match our patient's symptomatology since he has no rash or ocular complaints.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 61-year-old man presents with a two-week history of a sharp, stabbing pain over his right cheekbone. He describes the pain as 'very severe' and 'coming in spasms'. It typical lasts for around one minute before subsiding. The pain can be triggered by shaving and eating. Examination of his eyes, cranial nerves and mouth is unremarkable. What is the most likely diagnosis?",
        "correct_answer": "1",
        "question_notes": "The most likely diagnosis for this patient is <b>Trigeminal neuralgia</b>. Trigeminal neuralgia, also known as tic douloureux, is a severe facial pain disorder that affects the trigeminal or 5th cranial nerve. The symptoms described by the patient - sharp, stabbing pain over the cheekbone area that comes in spasms and can be triggered by routine activities such as shaving and eating - are characteristic of this condition. The pain typically lasts from a few seconds to several minutes.<br /><br /><b>Temporomandibular joint dysfunction</b> presents with symptoms such as difficulty opening the mouth wide, jaw clicking or popping sounds, earache, headache and facial ache. However, it does not typically cause sharp, stabbing pains that come in spasms and are triggered by routine activities like shaving or eating.<br /><br /><b>Temporal arteritis</b>, also known as giant cell arteritis, is an inflammation of the arteries in and around the scalp. This condition usually presents with new onset headache, scalp tenderness (especially over the temporal arteries), jaw claudication (pain with chewing) and visual disturbances. It doesn't align well with this patient's presentation.<br /><br />A <b>Cluster headache</b> is another type of primary headache disorder but its pain is usually located around one eye (periorbital) or on one side of the head. It's often accompanied by autonomic symptoms like tearing, nasal congestion or pupil changes on the same side of the headache which were not reported by this patient.<br /><br /><b>Herpes zoster ophthalmicus</b> involves the reactivation of varicella-zoster virus within the first division of the trigeminal nerve. It would present with a painful rash in a dermatomal distribution involving the forehead and potentially the eye along with other ocular symptoms if eye involvement occurs. This does not match our patient's symptomatology since he has no rash or ocular complaints.<br />",
        "answer_order": "1",
        "answer": "1",
        "title": "Trigeminal neuralgia",
        "body": "Trigeminal neuralgia is a pain syndrome characterised by severe unilateral pain. The vast majority of cases are idiopathic but compression of the trigeminal roots by tumours or vascular problems may occur.<br /><br />The International Headache Society defines trigeminal neuralgia as:<br /><ul><li>a unilateral disorder characterised by brief electric shock-like pains, abrupt in onset and termination, limited to one or more divisions of the trigeminal nerve</li><li>the pain is commonly evoked by light touch, including washing, shaving, smoking, talking, and brushing the teeth (trigger factors), and frequently occurs spontaneously</li><li>small areas in the nasolabial fold or chin may be particularly susceptible to the precipitation of pain (trigger areas)</li><li>the pains usually remit for variable periods</li></ul><br />The following as red flag symptoms and signs suggesting a serious underlying cause:<br /><ul><li>Sensory changes</li><li>Deafness or other ear problems</li><li>History of skin or oral lesions that could spread perineurally</li><li>Pain only in the ophthalmic division of the trigeminal nerve (eye socket, forehead, and nose), or bilaterally</li><li>Optic neuritis</li><li>A family history of multiple sclerosis</li><li>Age of onset before 40 years</li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"359\">carbamazepine is first-line</span></li><li>failure to respond to treatment or atypical features (e.g. < 50 years old) should prompt referral to neurology</li></ul>",
        "notes_hash": "19224ad02fa23ef96ac22e2df247707a",
        "knowledge_graph_node_id_link": 1052,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4269",
        "up_votes": "16",
        "down_votes": "13",
        "column_array": [
            0,
            "3803",
            "123",
            "291",
            "39",
            "13",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "359": {
                "concept_text": "Trigeminal neuralgia - carbamazepine is first-line",
                "concept_percentile": "56"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16300_B_1348",
        "new_question_id": "46769",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "3789",
        "notes_id_link": "1_2242",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Maintain the current dose of 200 micrograms, two puffs, twice daily",
            "Reduce to 100 micrograms, one puff, twice daily",
            "Reduce to 200 micrograms, one puff, twice daily",
            "Stop the beclometasone inhaler",
            "Switch to a long-acting beta agonist",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 36-year-old man presents to his general practitioner for an annual asthma review. He feels that his symptoms have been very well controlled over the past year, and he does not have to use his salbutamol inhaler at all. He currently uses a beclometasone inhaler - 200 micrograms per puff - and takes two puffs twice daily. On examination, he appears well and the examination is normal.<br /><br />What is the most appropriate next step in management?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "Although, in practice, patients are typically reviewed on an annual basis with regard to asthma, guidelines recommend stepping down treatment every 3 months. As this patient's asthma has been very well controlled for the past year, a step-down approach is reasonable. BTS guidelines advocate reducing inhaled steroids by 25-50% at a time. This patient is currently taking a total of 800 micrograms daily. As such, a reduction to 400-600 micrograms daily would be appropriate. The option that fits this description is to <b>reduce to 200 micrograms, one puff, twice daily</b>.<br /><br /><b>Maintaining the current dose of 200 micrograms, two puffs, twice daily</b> is incorrect. In practice, this may be what happens, but ideally, the patient should be stepped down.<br /><br /><b>Reducing to 100 micrograms, one puff, twice daily</b> is too far of a step down. This is a reduction of 75%, whereas guidelines suggest 25-50%.<br /><br /><b>Stopping the beclometasone inhaler</b> is unwise at this stage. A step-wise approach should be used to gradually reduce treatment. Otherwise, the patient is at risk of inadequate asthma control and future exacerbations.<br /><br /><b>Switching to a long-acting beta agonist</b> (LABA) is not appropriate. Adding a LABA would be considered if the patient's asthma control had deteriorated. The fact that he is not using his salbutamol inhaler (a short-acting beta agonist) suggests that adding a LABA is not indicated. Instead, the patient should be gradually stepped down on his beclometasone inhaler.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 36-year-old man presents to his general practitioner for an annual asthma review. He feels that his symptoms have been very well controlled over the past year, and he does not have to use his salbutamol inhaler at all. He currently uses a beclometasone inhaler - 200 micrograms per puff - and takes two puffs twice daily. On examination, he appears well and the examination is normal.<br /><br />What is the most appropriate next step in management?",
        "correct_answer": "3",
        "question_notes": "Although, in practice, patients are typically reviewed on an annual basis with regard to asthma, guidelines recommend stepping down treatment every 3 months. As this patient's asthma has been very well controlled for the past year, a step-down approach is reasonable. BTS guidelines advocate reducing inhaled steroids by 25-50% at a time. This patient is currently taking a total of 800 micrograms daily. As such, a reduction to 400-600 micrograms daily would be appropriate. The option that fits this description is to <b>reduce to 200 micrograms, one puff, twice daily</b>.<br /><br /><b>Maintaining the current dose of 200 micrograms, two puffs, twice daily</b> is incorrect. In practice, this may be what happens, but ideally, the patient should be stepped down.<br /><br /><b>Reducing to 100 micrograms, one puff, twice daily</b> is too far of a step down. This is a reduction of 75%, whereas guidelines suggest 25-50%.<br /><br /><b>Stopping the beclometasone inhaler</b> is unwise at this stage. A step-wise approach should be used to gradually reduce treatment. Otherwise, the patient is at risk of inadequate asthma control and future exacerbations.<br /><br /><b>Switching to a long-acting beta agonist</b> (LABA) is not appropriate. Adding a LABA would be considered if the patient's asthma control had deteriorated. The fact that he is not using his salbutamol inhaler (a short-acting beta agonist) suggests that adding a LABA is not indicated. Instead, the patient should be gradually stepped down on his beclometasone inhaler.",
        "answer_order": "3",
        "answer": "3",
        "title": "Asthma: stepping down treatment",
        "body": "The British Thoracic Society (BTS) guidelines recommend that we should consider stepping down treatment every 3 months or so. The guidelines don't advocate a strict move from say step 3 to step 2 but advise us to take into account duration of treatment, side-effects and patient preference.<br /><br />When reducing the dose of inhaled steroids the BTS advise us to do this by 25-50% at a time.<br /><br />Clearly patients with stable asthma may only have a formal review on an annual basis but it is likely that if a patient has recently had an escalation of asthma treatment they would be reviewed on a more frequent basis.",
        "notes_hash": "b82af58fd27a97e752463672a332fb95",
        "knowledge_graph_node_id_link": 11377,
        "concept": "In the step-down treatment of asthma, aim for a reduction of 25-50% in the dose of inhaled corticosteroids ",
        "concept_percentile": "90",
        "concept_colour": "rgb(50,255,0)",
        "number_attempts": "5756",
        "up_votes": "32",
        "down_votes": "35",
        "column_array": [
            0,
            "1865",
            "1099",
            "2474",
            "144",
            "174",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 5,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1991",
        "new_question_id": "1743",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "0",
        "notes_id_link": "1_1207",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "ERCP (Endoscopic Retrograde cholangiopancreatography)",
            "MRCP (Magnetic resonance cholangiopancreatography)",
            "Laparoscopic cholecystectomy at the time of nephrectomy",
            "Reassurance",
            "Laparoscopic cholecystectomy 3 months following nephrectomy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 35-year-old woman presents to GP following a staging CT for her recently diagnosed renal cell (RCC) carcinoma. She was told following the scan that there were gallstones present within her gall bladder and she wishes to discuss the management options with you. She has no history of abdominal pain and is fit and well otherwise. She is to undergo left-sided nephrectomy for her RCC in 3 weeks. <br /><br />On examination, her abdomen is soft and tender over the left flank. no masses are palpable.<br /><br />How should you manage this lady?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Reassure people with asymptomatic gallbladder stones.<br /><br />Stones that are found incidentally, as a result of imaging investigations unrelated to gallstone disease in people who have been completely symptom-free for at least 12 months before diagnosis do not require intervention. <br /><br />They must be found in a normal gallbladder and normal biliary tree. Symptomatic patients or those with stones within the common bile duct (CBD) do require intervention to clear the CBD.<br /><br />This can be done:<br /><ul><li>Surgically at the time of laparoscopic cholecystectomy or</li><li>With endoscopic retrograde cholangiopancreatography (ERCP) before or at the time of laparoscopic cholecystectomy.</li></ul><br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 35-year-old woman presents to GP following a staging CT for her recently diagnosed renal cell (RCC) carcinoma. She was told following the scan that there were gallstones present within her gall bladder and she wishes to discuss the management options with you. She has no history of abdominal pain and is fit and well otherwise. She is to undergo left-sided nephrectomy for her RCC in 3 weeks. <br /><br />On examination, her abdomen is soft and tender over the left flank. no masses are palpable.<br /><br />How should you manage this lady?",
        "correct_answer": "4",
        "question_notes": "Reassure people with asymptomatic gallbladder stones.<br /><br />Stones that are found incidentally, as a result of imaging investigations unrelated to gallstone disease in people who have been completely symptom-free for at least 12 months before diagnosis do not require intervention. <br /><br />They must be found in a normal gallbladder and normal biliary tree. Symptomatic patients or those with stones within the common bile duct (CBD) do require intervention to clear the CBD.<br /><br />This can be done:<br /><ul><li>Surgically at the time of laparoscopic cholecystectomy or</li><li>With endoscopic retrograde cholangiopancreatography (ERCP) before or at the time of laparoscopic cholecystectomy.</li></ul><br />",
        "answer_order": "4",
        "answer": "4",
        "title": "Gallstones",
        "body": "Up to 24% of women and 12% of men may have gallstones. Of these up to 30% may develop local infection and cholecystitis. In patients subjected to surgery, 12% will have stones contained within the common bile duct. The majority of gallstones are of a mixed composition (50%) with pure cholesterol stones accounting for 20% of cases. <br /><br />The aetiology of CBD stones differs in the world, in the West most CBD stones are the result of migration. In the East, a far higher proportion arise in the CBD de novo.<br /><br />The classical symptoms are of colicky right upper quadrant pain that occurs postprandially. The symptoms are usually worst following a fatty meal when cholecystokinin levels are highest and gallbladder contraction is maximal. <br /><br /><h5 class='notes-heading'>Investigation</h5><br />In almost all suspected cases the standard diagnostic workup consists of abdominal ultrasound and liver function tests. Of patients who have stones within the bile duct, 60% will have at least one abnormal result on LFT's. Ultrasound is an important test, but is operator dependent and therefore may occasionally need to be repeated if a negative result is at odds with the clinical picture. Where stones are suspected in the bile duct the options lie between magnetic resonance cholangiography and intraoperative imaging. The choice between these two options is determined by the skills and experience of the surgeon. The advantages of intraoperative imaging are less useful in making therapeutic decisions if the operator is unhappy about proceeding the bile duct exploration, and in such circumstances, preoperative MRCP is probably a better option.<br /><br /><h5 class='notes-heading'>Specific gallstone and gallbladder related disease</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Disease</b></th><th><b>Features</b></th><th><b>Management</b></th></tr></thead><tbody><tr><td>Biliary colic</td><td>Colicky abdominal pain, worse postprandially, worse after fatty foods</td><td>If imaging shows gallstones and history compatible then laparoscopic cholecystectomy</td></tr><tr><td>Acute cholecystitis</td><td>Right upper quadrant pain<br />Fever<br />Murphys sign on examination<br />Occasionally mildly deranged LFT's (especially if Mirizzi syndrome)</td><td>Imaging (USS) and cholecystectomy (ideally within 48 hours of presentation) (2)</td></tr><tr><td>Gallbladder abscess</td><td>Usually prodromal illness and right upper quadrant pain<br />Swinging pyrexia<br />Patient may be systemically unwell<br />Generalised peritonism not present</td><td>Imaging with USS +/- CT Scanning<br />Ideally, surgery although subtotal cholecystectomy may be needed if Calot's triangle is hostile<br />In unfit patients, percutaneous drainage may be considered</td></tr><tr><td>Cholangitis</td><td>Patient severely septic and unwell<br />Jaundice<br />Right upper quadrant pain</td><td>Fluid resuscitation<br />Broad-spectrum intravenous antibiotics<br />Correct any coagulopathy<br />Early ERCP</td></tr><tr><td>Gallstone ileus</td><td>Patients may have a history of previous cholecystitis and known gallstones<br />Small bowel obstruction (may be intermittent)</td><td>Laparotomy and removal of the gallstone from small bowel, the enterotomy must be made proximal to the site of obstruction and not at the site of obstruction. The fistula between the gallbladder and duodenum should not be interfered with.</td></tr><tr><td>Acalculous cholecystitis</td><td>Patients with intercurrent illness (e.g. diabetes, organ failure)<br />Patient of systemically unwell<br />Gallbladder inflammation in absence of stones<br />High fever</td><td>If patient fit then cholecystectomy, if unfit then percutaneous cholecystostomy</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Treatment</h5><br /><div class='alert alert-warning'>Asymptomatic gallstones which are located in the gallbladder are common and do not require treatment. However, if stones are present in the common bile duct there is an increased risk of complications such as cholangitis or pancreatitis and surgical management should be considered.<br /></div><br />Patients with asymptomatic gallstones rarely develop symptoms related to them (less than 2% per year) and may, therefore, be managed expectantly. In almost all cases of symptomatic gallstones the treatment of choice is cholecystectomy performed via the laparoscopic route. In the very frail patient, there is sometimes a role for the selective use of ultrasound guided cholecystostomy. <br /><br />During the course of the procedure, some surgeons will routinely perform either intraoperative cholangiography to either confirm anatomy or to exclude CBD stones. The latter may be more easily achieved by use of laparoscopic ultrasound. If stones are found then the options lie between early ERCP in the day or so following surgery or immediate surgical exploration of the bile duct. When performed via the trans cystic route this adds little in the way of morbidity and certainly results in faster recovery. Where transcystic exploration fails the alternative strategy is that of formal choledochotomy. The exploration of a small duct is challenging and ducts of less than 8mm should not be explored. Small stones that measure less than 5mm may be safely left and most will pass spontaneously. <br /><br />Risks of ERCP(1)<br /><ul><li>Bleeding 0.9% (rises to 1.5% if sphincterotomy performed)</li><li>Duodenal perforation 0.4%</li><li>Cholangitis 1.1%</li><li>Pancreatitis 1.5%</li></ul><br /><h5 class='notes-heading'>References</h5><br />1. Williams E <i>et al</i>. Guidelines on the management of common bile duct stones (CBDS)<i>Gut</i> 2008;57:10041021<br /><br />2. Gurusamy KS, Samraj K. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005440.",
        "notes_hash": "b34141d66b96395c69c5a0b5dd583fe8",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5128",
        "up_votes": "40",
        "down_votes": "23",
        "column_array": [
            0,
            "253",
            "267",
            "553",
            "3469",
            "586",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1288\" data-linkid=\"1288\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1288\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1288\" data-linkid=\"1288\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1288\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg188/chapter/1-Recommendations\">2014 Gallstone disease: diagnosis and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/d/d8/Gallstone_ileus.webm\" data-description=\"Gallstone ileus\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"34\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/d/d8/Gallstone_ileus.webm\" data-description=\"Gallstone ileus\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"34\">Gallstone ileus</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_62\" data-mediaid=\"62\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_62\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_62\" data-mediaid=\"62\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_62\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/6/6e/Ascending_cholangitis.webm\" data-description=\"Ascending cholangitis\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"975\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/6/6e/Ascending_cholangitis.webm\" data-description=\"Ascending cholangitis\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"975\">Ascending cholangitis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1728\" data-mediaid=\"1728\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1728\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1728\" data-mediaid=\"1728\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1728\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/qjv2hPWvTJo\" data-description=\"Understanding Gallstones\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1319\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/qjv2hPWvTJo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/qjv2hPWvTJo\" data-description=\"Understanding Gallstones\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1319\">Understanding Gallstones</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2327\" data-mediaid=\"2327\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2327\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2327\" data-mediaid=\"2327\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2327\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dGdQ-xWXOTE\" data-description=\"Acute Cholecystitis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"259\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/dGdQ-xWXOTE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dGdQ-xWXOTE\" data-description=\"Acute Cholecystitis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"259\">Acute Cholecystitis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_442\" data-mediaid=\"442\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_442\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_442\" data-mediaid=\"442\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_442\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UPw3ot1M_o0\" data-description=\"Gallstones (cholelithiasis)\" data-upvotes=\"0\" data-downvotes=\"2\" data-media=\"23\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/UPw3ot1M_o0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UPw3ot1M_o0\" data-description=\"Gallstones (cholelithiasis)\" data-upvotes=\"0\" data-downvotes=\"2\" data-media=\"23\">Gallstones (cholelithiasis)</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_46\" data-mediaid=\"46\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_46\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_46\" data-mediaid=\"46\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_46\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2211",
        "new_question_id": "61342",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "319",
        "notes_id_link": "1_1504",
        "theme": "Management of extensive dermatophyte onychomycosis",
        "instruction": "",
        "options": [
            "",
            "Oral terbinafine",
            "Topical amorolfine",
            "Oral itraconazole",
            "Oral fluconazole",
            "Reassurance and nail care advice",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 65-year-old man with type 2 diabetes presents with thickened, yellow toenails. Nail clippings have confirmed a dermatophyte infection. Four nails are affected, with changes extending to the nail bed. He is bothered by their appearance.<br /><br />Select the single most appropriate management from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Oral terbinafine</b> is the most appropriate management. This patient has a confirmed dermatophyte nail infection (onychomycosis) that is extensive, affecting four nails with involvement of the nail bed. According to UK guidelines (NICE CKS), systemic antifungal therapy is indicated for extensive disease, and oral terbinafine is the first-line agent for dermatophyte infections. The extent of disease is typically defined as affecting more than two nails, involvement of the nail matrix (lunula), or significant nail plate involvement (>50%). This patient's presentation clearly meets the criteria for systemic treatment. Terbinafine is an allylamine antifungal which is fungicidal against dermatophytes like <i>Trichophyton rubrum</i>, the most common causative organism. Treatment for toenail infections typically lasts for 3 to 6 months. It is important that mycological confirmation is obtained before commencing oral therapy due to the long treatment duration and potential for side effects, which has been appropriately done in this scenario. Given the patient is bothered by the appearance and has diabetes (a risk factor for complications like secondary cellulitis), active treatment is warranted.<br /><br /><b>Topical amorolfine</b> is an incorrect choice. While amorolfine 5% nail lacquer is an effective treatment for onychomycosis, its use is reserved for limited and superficial disease. Guidelines suggest topical therapy is appropriate only when two or fewer nails are affected, the infection involves less than 50% of the distal nail plate, and there is no involvement of the nail matrix (lunula). This patient has four affected nails with changes extending to the nail bed, indicating a more deep-seated and extensive infection. In such cases, topical agents have poor penetration and are associated with high rates of treatment failure. Therefore, systemic therapy is required to achieve a clinical and mycological cure.<br /><br /><b>Oral itraconazole</b> is not the first-line choice in this case. Itraconazole is a broad-spectrum triazole antifungal that is effective against dermatophytes, but UK guidelines recommend it as a second-line option if terbinafine is contraindicated, not tolerated, or has failed. Terbinafine is generally preferred due to slightly higher cure rates for dermatophyte infections and a different side effect profile. Itraconazole is, however, the first-line oral agent for onychomycosis caused by <i>Candida</i> species. Since this patient has a confirmed dermatophyte infection and no stated contraindication to terbinafine, terbinafine should be used first.<br /><br /><b>Oral fluconazole</b> is not a recommended first-line treatment for dermatophyte onychomycosis in the UK. Although it is licensed for this indication, its efficacy against dermatophytes is generally considered lower than that of terbinafine and itraconazole. It is often used off-licence in a once-weekly regimen, but cure rates are inferior. Its main utility is in the management of mucocutaneous candidiasis. Given the availability of more effective first-line agents for a confirmed dermatophyte infection, fluconazole would be an inappropriate choice.<br /><br /><b>Reassurance and nail care advice</b> would be inappropriate for this patient. This management option is suitable for individuals with asymptomatic onychomycosis who are not concerned by the cosmetic appearance of their nails, as the condition is often benign. However, the scenario explicitly states that this patient is 'bothered by their appearance', indicating a desire for active treatment. Furthermore, in patients with comorbidities such as type 2 diabetes, treating onychomycosis can be important to reduce the risk of secondary bacterial infection, cellulitis, or foot ulceration. Therefore, withholding active treatment is not the most appropriate course of action.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 65-year-old man with type 2 diabetes presents with thickened, yellow toenails. Nail clippings have confirmed a dermatophyte infection. Four nails are affected, with changes extending to the nail bed. He is bothered by their appearance.<br /><br />Select the single most appropriate management from the options below.",
        "correct_answer": "1",
        "question_notes": "<b>Oral terbinafine</b> is the most appropriate management. This patient has a confirmed dermatophyte nail infection (onychomycosis) that is extensive, affecting four nails with involvement of the nail bed. According to UK guidelines (NICE CKS), systemic antifungal therapy is indicated for extensive disease, and oral terbinafine is the first-line agent for dermatophyte infections. The extent of disease is typically defined as affecting more than two nails, involvement of the nail matrix (lunula), or significant nail plate involvement (>50%). This patient's presentation clearly meets the criteria for systemic treatment. Terbinafine is an allylamine antifungal which is fungicidal against dermatophytes like <i>Trichophyton rubrum</i>, the most common causative organism. Treatment for toenail infections typically lasts for 3 to 6 months. It is important that mycological confirmation is obtained before commencing oral therapy due to the long treatment duration and potential for side effects, which has been appropriately done in this scenario. Given the patient is bothered by the appearance and has diabetes (a risk factor for complications like secondary cellulitis), active treatment is warranted.<br /><br /><b>Topical amorolfine</b> is an incorrect choice. While amorolfine 5% nail lacquer is an effective treatment for onychomycosis, its use is reserved for limited and superficial disease. Guidelines suggest topical therapy is appropriate only when two or fewer nails are affected, the infection involves less than 50% of the distal nail plate, and there is no involvement of the nail matrix (lunula). This patient has four affected nails with changes extending to the nail bed, indicating a more deep-seated and extensive infection. In such cases, topical agents have poor penetration and are associated with high rates of treatment failure. Therefore, systemic therapy is required to achieve a clinical and mycological cure.<br /><br /><b>Oral itraconazole</b> is not the first-line choice in this case. Itraconazole is a broad-spectrum triazole antifungal that is effective against dermatophytes, but UK guidelines recommend it as a second-line option if terbinafine is contraindicated, not tolerated, or has failed. Terbinafine is generally preferred due to slightly higher cure rates for dermatophyte infections and a different side effect profile. Itraconazole is, however, the first-line oral agent for onychomycosis caused by <i>Candida</i> species. Since this patient has a confirmed dermatophyte infection and no stated contraindication to terbinafine, terbinafine should be used first.<br /><br /><b>Oral fluconazole</b> is not a recommended first-line treatment for dermatophyte onychomycosis in the UK. Although it is licensed for this indication, its efficacy against dermatophytes is generally considered lower than that of terbinafine and itraconazole. It is often used off-licence in a once-weekly regimen, but cure rates are inferior. Its main utility is in the management of mucocutaneous candidiasis. Given the availability of more effective first-line agents for a confirmed dermatophyte infection, fluconazole would be an inappropriate choice.<br /><br /><b>Reassurance and nail care advice</b> would be inappropriate for this patient. This management option is suitable for individuals with asymptomatic onychomycosis who are not concerned by the cosmetic appearance of their nails, as the condition is often benign. However, the scenario explicitly states that this patient is 'bothered by their appearance', indicating a desire for active treatment. Furthermore, in patients with comorbidities such as type 2 diabetes, treating onychomycosis can be important to reduce the risk of secondary bacterial infection, cellulitis, or foot ulceration. Therefore, withholding active treatment is not the most appropriate course of action.",
        "answer_order": "1",
        "answer": "1",
        "title": "Fungal nail infections",
        "body": "Fungal nail infection (onychomycosis) may involve any part of the nail, or the entire nail unit. Toenails are significantly more likely to become infected than fingernails<br /><br />Causative organisms<br /><ul><li>dermatophytes<ul><li>account for around 90% of cases</li><li>mainly <i>Trichophyton rubrum</i></li></ul></li><li>yeasts<ul><li>account for around 5-10% of cases</li><li>e.g. <i>Candida</i></li></ul></li><li>non-dermatophyte moulds</li></ul><br />Risk factors<br /><ul><li>increasing age</li><li>diabetes mellitus</li><li>psoriasis</li><li>repeated nail trauma</li></ul><br />Features<br /><ul><li>'unsightly' nails are a common reason for presentation</li><li>thickened, rough, opaque nails are the most common finding</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd959b.jpg\" data-fancybox=\"gallery\" data-caption=\"Extensive dermatophyte infection of a toe nail\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd959.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img009b.jpg\" data-fancybox=\"gallery\" data-caption=\"Fungal nail infection\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img009.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd960b.jpg\" data-fancybox=\"gallery\" data-caption=\"Fungal nail infection\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd960.jpg\" alt=\"\" /></a></div></div></div><br />Differential diagnosis<br /><ul><li>psoriasis</li><li>repeated trauma</li><li>lichen planus</li><li>yellow nail syndrome</li></ul><br />Investigation<br /><ul><li>nail clippings +/- scrapings of the affected nail<ul><li>microscopy and culture</li><li><span class=\"concept\" data-cid=\"10235\">should be done for all patients if antifungal treatment is being considered</span></li><li>the false-negative rate for cultures are around 30%, so repeat samples may need to be sent if the clinical suspicion is high</li></ul></li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"10234\">do not need to be treated if it is asymptomatic</span> and the patient is not bothered by the appearance</li><li>if dermatophyte or <i>Candida</i> infection is confirmed <ul><li>if limited involvement (\u226450% nail affected, \u2264 2 nails affected, more superficial white onychomycosis): topical treatment with amorolfine 5% nail lacquer;  6 months for fingernails and 9 - 12 months for toenails</li><li>if more extensive involvement due to a dermatophyte infection: <span class=\"concept\" data-cid=\"319\">oral terbinafine</span> is currently recommended first-line; 6 weeks - 3 months therapy is needed for fingernail infections whilst toenails should be treated for 3 - 6 months</li><li>if more extensive involvement due to a <i>Candida</i> infection: oral itraconazole is recommended first-line; 'pulsed' weekly therapy is recommended</li></ul></li></ul>",
        "notes_hash": "ed643b57b78e4f249f52f2a9d33fea6a",
        "knowledge_graph_node_id_link": 0,
        "concept": "Dermatophyte nail infections - use oral terbinafine",
        "concept_percentile": "62",
        "concept_colour": "rgb(193,255,0)",
        "number_attempts": "119",
        "up_votes": "0",
        "down_votes": "1",
        "column_array": [
            0,
            "105",
            "7",
            "4",
            "3",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1305\" data-linkid=\"1305\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1305\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_1305\" data-linkid=\"1305\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1305\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/fungal-nail-infections/\">Fungal nail infections</a></td></tr></table>",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": {
            "319": {
                "concept_text": "Dermatophyte nail infections - use oral terbinafine",
                "concept_percentile": "62"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2144",
        "new_question_id": "61225",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "5341",
        "notes_id_link": "1_1606",
        "theme": "Investigation to confirm ovulation in primary care",
        "instruction": "",
        "options": [
            "",
            "Serum follicle-stimulating hormone",
            "Serum luteinising hormone",
            "Serum oestradiol",
            "Serum progesterone",
            "Pelvic ultrasound scan",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 29-year-old woman and her partner attend their GP. They have been trying to conceive for 14 months. She has a regular 28-day menstrual cycle. Her partner's semen analysis is normal. <br /><br />Select the single most appropriate investigation to confirm ovulation.",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "<b>Serum progesterone</b> is the correct answer. According to NICE guidelines, the most appropriate initial investigation to confirm ovulation in a woman with a regular menstrual cycle is a mid-luteal phase serum progesterone test. In a typical 28-day cycle, the luteal phase begins after ovulation (around day 14). The test should be performed 7 days before the expected next period, which corresponds to day 21 in this patient's 28-day cycle. The corpus luteum, which forms from the follicle after ovulation, produces progesterone. A sufficiently high level (typically >30 nmol/L in the UK) provides strong evidence that ovulation has occurred. Levels between 16-30 nmol/L are equivocal and may need repeating, while levels <16 nmol/L suggest anovulation. This simple blood test is the standard, first-line method for confirming ovulation in primary care.<br /><br /><b>Serum follicle-stimulating hormone</b> (FSH) is an important investigation in the context of infertility, but it does not confirm ovulation. FSH is typically measured in the early follicular phase (days 2-5 of the cycle). Its primary purpose is to assess ovarian reserve. An elevated basal FSH level can suggest diminished ovarian reserve, indicating a reduced number of remaining follicles. While this is a key part of the overall fertility assessment, it provides information about a woman's reproductive potential rather than confirming the event of ovulation in a specific cycle.<br /><br /><b>Serum luteinising hormone</b> (LH) measurement is used to predict, not confirm, ovulation. A surge in LH levels triggers the final maturation and rupture of the ovarian follicle, leading to ovulation approximately 24-36 hours later. Urine ovulation predictor kits work by detecting this LH surge. While a blood test can also measure this, the presence of an LH surge does not guarantee that ovulation will successfully occur. Therefore, it is not the definitive test to confirm that the event has taken place. Progesterone measurement, which assesses the function of the post-ovulatory corpus luteum, is the confirmatory test.<br /><br /><b>Serum oestradiol</b> is another hormone involved in the menstrual cycle, produced by the developing follicle. Its levels rise during the follicular phase, peaking just before the LH surge. It is often measured alongside FSH on days 2-5 as part of an ovarian reserve assessment. High basal oestradiol can mask an elevated FSH, providing a more complete picture of ovarian function. However, like LH, its levels indicate follicular activity and the lead-up to ovulation, but it does not confirm that ovulation has been successfully completed.<br /><br /><b>Pelvic ultrasound scan</b> can be used to confirm ovulation, but it is not the most appropriate initial investigation in this setting. Serial transvaginal ultrasound scans (follicle tracking) can monitor the growth of a dominant follicle and subsequently confirm its collapse or the presence of a corpus luteum, which are signs of ovulation. However, this is a more specialist, resource-intensive, and invasive procedure compared to a single blood test. It is typically reserved for specialist fertility clinics, often during ovulation induction cycles, rather than as a first-line test in primary care.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 29-year-old woman and her partner attend their GP. They have been trying to conceive for 14 months. She has a regular 28-day menstrual cycle. Her partner's semen analysis is normal. <br /><br />Select the single most appropriate investigation to confirm ovulation.",
        "correct_answer": "4",
        "question_notes": "<b>Serum progesterone</b> is the correct answer. According to NICE guidelines, the most appropriate initial investigation to confirm ovulation in a woman with a regular menstrual cycle is a mid-luteal phase serum progesterone test. In a typical 28-day cycle, the luteal phase begins after ovulation (around day 14). The test should be performed 7 days before the expected next period, which corresponds to day 21 in this patient's 28-day cycle. The corpus luteum, which forms from the follicle after ovulation, produces progesterone. A sufficiently high level (typically >30 nmol/L in the UK) provides strong evidence that ovulation has occurred. Levels between 16-30 nmol/L are equivocal and may need repeating, while levels <16 nmol/L suggest anovulation. This simple blood test is the standard, first-line method for confirming ovulation in primary care.<br /><br /><b>Serum follicle-stimulating hormone</b> (FSH) is an important investigation in the context of infertility, but it does not confirm ovulation. FSH is typically measured in the early follicular phase (days 2-5 of the cycle). Its primary purpose is to assess ovarian reserve. An elevated basal FSH level can suggest diminished ovarian reserve, indicating a reduced number of remaining follicles. While this is a key part of the overall fertility assessment, it provides information about a woman's reproductive potential rather than confirming the event of ovulation in a specific cycle.<br /><br /><b>Serum luteinising hormone</b> (LH) measurement is used to predict, not confirm, ovulation. A surge in LH levels triggers the final maturation and rupture of the ovarian follicle, leading to ovulation approximately 24-36 hours later. Urine ovulation predictor kits work by detecting this LH surge. While a blood test can also measure this, the presence of an LH surge does not guarantee that ovulation will successfully occur. Therefore, it is not the definitive test to confirm that the event has taken place. Progesterone measurement, which assesses the function of the post-ovulatory corpus luteum, is the confirmatory test.<br /><br /><b>Serum oestradiol</b> is another hormone involved in the menstrual cycle, produced by the developing follicle. Its levels rise during the follicular phase, peaking just before the LH surge. It is often measured alongside FSH on days 2-5 as part of an ovarian reserve assessment. High basal oestradiol can mask an elevated FSH, providing a more complete picture of ovarian function. However, like LH, its levels indicate follicular activity and the lead-up to ovulation, but it does not confirm that ovulation has been successfully completed.<br /><br /><b>Pelvic ultrasound scan</b> can be used to confirm ovulation, but it is not the most appropriate initial investigation in this setting. Serial transvaginal ultrasound scans (follicle tracking) can monitor the growth of a dominant follicle and subsequently confirm its collapse or the presence of a corpus luteum, which are signs of ovulation. However, this is a more specialist, resource-intensive, and invasive procedure compared to a single blood test. It is typically reserved for specialist fertility clinics, often during ovulation induction cycles, rather than as a first-line test in primary care.",
        "answer_order": "4",
        "answer": "4",
        "title": "Infertility: causes and initial investigations",
        "body": "Infertility affects around 1 in 7 couples. Around 84% of couples who have regular sex will conceive within 1 year, and 92% within 2 years<br /><br />Causes<br /><ul><li><span class=\"concept\" data-cid=\"9051\">male factor 30%</span></li><li>unexplained 20%</li><li>ovulation failure 20%</li><li>tubal damage 15%</li><li>other causes 15%</li></ul><br />Basic investigations<br /><ul><li>semen analysis</li><li><span class=\"concept\" data-cid=\"5253\">serum progesterone 7 days prior to expected next period</span>. For a typical 28 day cycle, this is done on <span class=\"concept\" data-cid=\"5341\">day 21</span>.</li></ul><br /><h5 class='notes-heading'>Interpretation of serum progestogen</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Level</b></th><th><b>Interpretation</b></th></tr></thead><tbody><tr><td>< 16 nmol/l</td><td>Repeat, if consistently low refer to specialist</td></tr><tr><td>16 - 30 nmol/l</td><td>Repeat</td></tr><tr><td>> 30 nmol/l</td><td>Indicates ovulation</td></tr></tbody></table></div><br />Key counselling points<br /><ul><li>folic acid</li><li>aim for BMI 20-25</li><li>advise regular sexual intercourse every 2 to 3 days</li><li>smoking/drinking advice</li></ul>",
        "notes_hash": "2e5c80cf5d6fcec0fb73a779be791ae9",
        "knowledge_graph_node_id_link": 10337,
        "concept": "Day 21 progesterone test is the most reliable test to confirm ovulation",
        "concept_percentile": "77",
        "concept_colour": "rgb(117,255,0)",
        "number_attempts": "115",
        "up_votes": "0",
        "down_votes": "0",
        "column_array": [
            0,
            "11",
            "14",
            "1",
            "88",
            "1",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_300\" data-linkid=\"300\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_300\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_300\" data-linkid=\"300\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_300\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg156/chapter/Recommendations\">2013 Infertility guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/0ZCEEY0cecA\" data-description=\"Understanding infertility\" data-upvotes=\"7\" data-downvotes=\"0\" data-media=\"786\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/0ZCEEY0cecA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/0ZCEEY0cecA\" data-description=\"Understanding infertility\" data-upvotes=\"7\" data-downvotes=\"0\" data-media=\"786\">Understanding infertility</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1367\" data-mediaid=\"1367\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1367\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1367\" data-mediaid=\"1367\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1367\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/JhmTvH3trPQ\" data-description=\"Infertility in Women (causes and pathophysiology)\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"401\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/JhmTvH3trPQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/JhmTvH3trPQ\" data-description=\"Infertility in Women (causes and pathophysiology)\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"401\">Infertility in Women (causes and pathophysiology)</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_687\" data-mediaid=\"687\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_687\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_687\" data-mediaid=\"687\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_687\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "5253": {
                "concept_text": "To confirm ovulation: Take the serum progesterone level 7 days prior to the expected next period",
                "concept_percentile": "87"
            },
            "5341": {
                "concept_text": "Day 21 progesterone test is the most reliable test to confirm ovulation",
                "concept_percentile": "77"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5650_B_378",
        "new_question_id": "32524",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "10625",
        "notes_id_link": "1_2735",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Aciclovir",
            "Amitriptyline",
            "Chlorphenamine",
            "Flucloxacillin",
            "Prednisolone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 27-year-old man presents to the emergency department with a 2-day history of fever, tiredness, and a tingling sensation in the lateral aspect of his right thigh. He has found the tingling was initially bearable but has become painful in the past 24 hours. On examination, the area described is erythematous with a macular rash appearing. His only past medical history is HIV for which he takes anti-retroviral therapy and has an undetectable viral load. He denies any cough, coryzal symptoms, focal neurological signs, or trauma to the site.<br /><br />Considering the likely diagnosis, what is the appropriate management for the patient out of the options listed?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "This patient is presenting within 72 hours of symptoms of shingles - he has systemic viral illness symptoms (fever and malaise) with tingling and pain over the L2 dermatomal distribution (lateral aspect of his thigh). As he has an immunosuppressive condition (HIV), he should be managed with antivirals, such as <b>aciclovir</b>, to reduce the risk of post-herpetic complications. <br /><br /><b>Amitriptyline</b> is recommended for the management of post-herpetic neuralgia. As this patient is presenting with symptoms of shingles, it would be inappropriate to treat him for post-herpetic neuralgia. Post-herpetic neuralgia is one of the main complications after shingles, and the prescription of anti-virals within 72 hours of presentation aims to reduce this risk.<br /><br /><b>Chlorphenamine</b> is used in the management of chickenpox. It is recommended to reduce the itching associated with the lesions that occur. As this patient appears to only have one dermatome affected - it is more likely to be shingles, rather than chickenpox which tends to affect the whole body. <br /><br /><b>Flucloxacillin</b> is an antibiotic used to manage bacterial skin infections. This patient has systemic features of infection, however, it would be inappropriate to prescribe antibiotics as his symptoms are more consistent with herpes zoster infection. <br /><br /><b>Prednisolone</b> is a second line analgesic agent which is prescribed for patients who are not adequately pain-free with over-the-counter analgesia. As this patient has not been trialled with any simple analgesia, he should be given this first. Furthermore, this will not reduce the likelihood of developing post-herpetic complications (which is one of the main reasons for prescribing anti-virals).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 27-year-old man presents to the emergency department with a 2-day history of fever, tiredness, and a tingling sensation in the lateral aspect of his right thigh. He has found the tingling was initially bearable but has become painful in the past 24 hours. On examination, the area described is erythematous with a macular rash appearing. His only past medical history is HIV for which he takes anti-retroviral therapy and has an undetectable viral load. He denies any cough, coryzal symptoms, focal neurological signs, or trauma to the site.<br /><br />Considering the likely diagnosis, what is the appropriate management for the patient out of the options listed?",
        "correct_answer": "1",
        "question_notes": "This patient is presenting within 72 hours of symptoms of shingles - he has systemic viral illness symptoms (fever and malaise) with tingling and pain over the L2 dermatomal distribution (lateral aspect of his thigh). As he has an immunosuppressive condition (HIV), he should be managed with antivirals, such as <b>aciclovir</b>, to reduce the risk of post-herpetic complications. <br /><br /><b>Amitriptyline</b> is recommended for the management of post-herpetic neuralgia. As this patient is presenting with symptoms of shingles, it would be inappropriate to treat him for post-herpetic neuralgia. Post-herpetic neuralgia is one of the main complications after shingles, and the prescription of anti-virals within 72 hours of presentation aims to reduce this risk.<br /><br /><b>Chlorphenamine</b> is used in the management of chickenpox. It is recommended to reduce the itching associated with the lesions that occur. As this patient appears to only have one dermatome affected - it is more likely to be shingles, rather than chickenpox which tends to affect the whole body. <br /><br /><b>Flucloxacillin</b> is an antibiotic used to manage bacterial skin infections. This patient has systemic features of infection, however, it would be inappropriate to prescribe antibiotics as his symptoms are more consistent with herpes zoster infection. <br /><br /><b>Prednisolone</b> is a second line analgesic agent which is prescribed for patients who are not adequately pain-free with over-the-counter analgesia. As this patient has not been trialled with any simple analgesia, he should be given this first. Furthermore, this will not reduce the likelihood of developing post-herpetic complications (which is one of the main reasons for prescribing anti-virals).",
        "answer_order": "1",
        "answer": "1",
        "title": "Shingles",
        "body": "Shingles (herpes zoster infection) is an acute, unilateral, painful blistering rash caused by reactivation of the varicella-zoster virus (VZV). Following primary infection with VZV (chickenpox), the virus <span class=\"concept\" data-cid=\"11185\">lies dormant in the dorsal root or cranial nerve ganglia</span>.<br /><br />Risk factors<br /><ul><li>increasing age</li><li><span class=\"concept\" data-cid=\"11186\">HIV</span>: strong risk factor, 15 times more common</li><li>other immunosuppressive conditions (e.g. steroids, chemotherapy)</li></ul><br />The most commonly affected dermatomes are T1-L2.<br /><br /><span class=\"concept\" data-cid=\"11183\">Features</span><br /><ul><li>prodromal period<ul><li>burning pain over the affected dermatome for 2-3 days</li><li>pain may be severe and interfere with sleep</li><li>around 20% of patients will experience fever, headache, lethargy</li></ul></li><li>rash<ul><li>initially erythematous, macular rash over the affected dermatome</li><li>quickly becomes vesicular</li><li>characteristically is well demarcated by the dermatome and does not cross the midline. However, some 'bleeding' into adjacent areas may be seen</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd557b.jpg\" data-fancybox=\"gallery\" data-caption=\"Herpes zoster in the T3 distribution\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd557.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img024.jpg\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img024.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/sm-dn-001.jpg\" data-fancybox=\"gallery\" data-caption=\"Image from DermNet NZ <a href='https://creativecommons.org/licenses/by-nc-nd/3.0/nz/legalcode'>Creative Commons Licence</a>\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/sm-dn-001.jpg\" alt=\"\" /></a></div></div></div><br />The <span class=\"concept\" data-cid=\"11184\">diagnosis is usually clinical</span>.<br /><br />Management<br /><ul><li>remind patients they are potentially infectious<ul><li>may need to avoid pregnant women and the immunosuppressed</li><li>should be advised that they are infectious until the <span class=\"concept\" data-cid=\"2703\">vesicles have crusted over, usually 5-7 days</span> following onset </li><li>covering lesions reduces the risk</li></ul></li><li>analgesia<ul><li>paracetamol and NSAIDs are first-line</li><li>if not responding then use of neuropathic agents (e.g. amitriptyline) can be considered</li><li><span class=\"concept\" data-cid=\"2705\">oral corticosteroids</span> may be considered in the first 2 weeks in immunocompetent adults with localized shingles if the pain is severe and not responding to the above treatments</li></ul></li><li>antivirals<ul><li>NICE makes recommendations on when to use antivirals</li><li>in practice, they recommend <span class=\"concept\" data-cid=\"10625\">antivirals within 72 hours for the majority of patients</span>, unless the patient is < 50 years and has a 'mild' truncal rash associated with mild pain and no underlying risk factors</li><li>one of the benefits of prescribing antivirals is a <span class=\"concept\" data-cid=\"11187\">reduced incidence of post-herpetic neuralgia</span>, particularly in older people</li><li>aciclovir, famciclovir, or valaciclovir are recommended</li></ul></li></ul><br />Complications<br /><ul><li><span class=\"concept\" data-cid=\"11188\">post-herpetic neuralgia</span><ul><li>the most common complications</li><li>more common in older patients</li><li>affects between 5%-30% of patients depending on age</li><li>most commonly resolves with 6 months but may last longer</li></ul></li><li>herpes zoster ophthalmicus (shingles affecting affecting the ocular division of the trigeminal nerve) is associated with a variety of ocular complications</li><li>herpes zoster oticus (Ramsay Hunt syndrome): may result in ear lesions and facial paralysis</li></ul>",
        "notes_hash": "882301263df469e92720b380e5135acd",
        "knowledge_graph_node_id_link": 1331,
        "concept": "The majority of patients with suspected shingles should be treated with antivirals within 72 hours of onset",
        "concept_percentile": "77",
        "concept_colour": "rgb(117,255,0)",
        "number_attempts": "7252",
        "up_votes": "31",
        "down_votes": "19",
        "column_array": [
            0,
            "5667",
            "651",
            "87",
            "443",
            "404",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SiAzOj7E5Yo\" data-description=\"Spinal Cord - Clinical Anatomy and Physiology (dermatomes, blood supply, shingles, lumbar puncture)\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"820\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/SiAzOj7E5Yo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SiAzOj7E5Yo\" data-description=\"Spinal Cord - Clinical Anatomy and Physiology (dermatomes, blood supply, shingles, lumbar puncture)\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"820\">Spinal Cord - Clinical Anatomy and Physiology (dermatomes, blood supply, shingles, lumbar puncture)</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1434\" data-mediaid=\"1434\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1434\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1434\" data-mediaid=\"1434\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1434\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "10625": {
                "concept_text": "The majority of patients with suspected shingles should be treated with antivirals within 72 hours of onset",
                "concept_percentile": "77"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5716_B_62",
        "new_question_id": "17622",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "5381",
        "notes_id_link": "1_2935",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Aspirin",
            "Clopidogrel",
            "Fondaparinux",
            "Nitrates",
            "Metoclopramide",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 60-year-old man presents to the emergency department with a sudden central chest pain. He has a past history of diabetes mellitus. On examination, he is alert but appears to be in pain and feeling nauseous. He has a pulse rate of 96 beats per minute and a blood pressure of 85/60 mmHg. ECG shows an ST-depression in the inferior leads.<br /><br />Which of the following medications is contraindicated in this patient?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The patient has a low systolic blood pressure (< 90 mmHg) which is a contraindication in nitrates such as glyceryl trinitrate. Nitrates have vasodilator effects, including peripheral venodilating properties which result in decreased venous return, ultimately causing hypotension. Other contraindications of nitrates are bradycardia (< 50 beats per minute) and history of recent (24-48 hours) phosphodiesterase-5 inhibitor use (sildenafil, tadalafil). The most likely diagnosis in this patient is an acute coronary syndrome (ACS). Aspirin, clopidogrel, fondaparinux and metoclopramide are not contraindicated in this patient and can be considered in an ACS.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 60-year-old man presents to the emergency department with a sudden central chest pain. He has a past history of diabetes mellitus. On examination, he is alert but appears to be in pain and feeling nauseous. He has a pulse rate of 96 beats per minute and a blood pressure of 85/60 mmHg. ECG shows an ST-depression in the inferior leads.<br /><br />Which of the following medications is contraindicated in this patient?",
        "correct_answer": "4",
        "question_notes": "The patient has a low systolic blood pressure (< 90 mmHg) which is a contraindication in nitrates such as glyceryl trinitrate. Nitrates have vasodilator effects, including peripheral venodilating properties which result in decreased venous return, ultimately causing hypotension. Other contraindications of nitrates are bradycardia (< 50 beats per minute) and history of recent (24-48 hours) phosphodiesterase-5 inhibitor use (sildenafil, tadalafil). The most likely diagnosis in this patient is an acute coronary syndrome (ACS). Aspirin, clopidogrel, fondaparinux and metoclopramide are not contraindicated in this patient and can be considered in an ACS.",
        "answer_order": "4",
        "answer": "4",
        "title": "Acute coronary syndrome: initial management",
        "body": "Acute coronary syndrome (ACS) is a very common and important presentation in medicine. The management of ACS has evolved over recent years, with the development of new drugs and procedures such as percutaneous coronary intervention (PCI).<br /><br />Emergency departments often have their own protocols based on local factors such as the availability of PCI and hospital drug formularies. The following is based on the 2020 update to the NICE ACS guidelines.<br /><br />Acute coronary syndrome can be classified as follows:<br /><ul><li>ST-elevation myocardial infarction (STEMI): ST-segment elevation + elevated biomarkers of myocardial damage</li><li>non ST-elevation myocardial infarction (NSTEMI): ECG changes but no ST-segment elevation + elevated biomarkers of myocardial damage</li><li>unstable angina</li></ul><br />The management of ACS depends on the particular subtype. NICE management guidance groups the patients into two groups:<br /><ul><li>1. STEMI</li><li>2. NSTEM/unstable angina</li></ul><br /><h5 class='notes-heading'>Common management of all patients with ACS</h5><br />Initial drug therapy<br /><ul><li><span class=\"concept\" data-cid=\"11121\">aspirin 300mg</span></li><li><span class=\"concept\" data-cid=\"11122\">oxygen should only be given if the patient has oxygen saturations < 94%</span> in keeping with British Thoracic Society oxygen therapy guidelines</li><li><span class=\"concept\" data-cid=\"11123\">morphine should only be given for patients with severe pain</span><ul><li>previously IV morphine was given routinely</li><li>evidence, however, suggests that this may be associated with adverse outcomes </li></ul></li><li>nitrates<ul><li>can be given either sublingually or intravenously</li><li>useful if the patient has ongoing chest pain or hypertension</li><li><span class=\"concept\" data-cid=\"11124\">should be used in caution if patient hypotensive</span></li></ul></li></ul><br />The next step in managing a patient with suspected ACS is to determine whether they meet the ECG criteria for STEMI. It is, of course, important to recognise that these criteria should be interpreted in the context of the clinical history.<br /><br /><span class=\"concept\" data-cid=\"11116\">STEMI criteria</span><br /><ul><li>clinical symptoms consistent with ACS (generally of \u2265 20 minutes duration) with persistent (> 20 minutes) ECG features in \u2265 2 contiguous leads of:<ul><li>2.5 mm (i.e \u2265 2.5 small squares) ST elevation in leads V2-3 in men under 40 years, or \u2265 2.0 mm (i.e \u2265 2 small squares) ST elevation in leads V2-3 in men over 40 years</li><li>1.5 mm ST elevation in V2-3 in women</li><li>1 mm ST elevation in other leads</li><li>new LBBB (LBBB should be considered new unless there is evidence otherwise)</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg072b.png\" data-fancybox=\"gallery\" data-caption=\"ECG shows in STEMI, ST elevation in V1-5. Deep QS waves in V2-V4, and small Q waves in V5 and V6. Angiogram showed LAD occlusion \u00a9 Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg072.png\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg073b.png\" data-fancybox=\"gallery\" data-caption=\"ECG showing a STEMI secondary to LAD occlusion \u00a9 Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg073.png\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg112b.png\" data-fancybox=\"gallery\" data-caption=\"This ECG shows sinus rhythm with marked ST elevation in V1\u2013V2 and reciprocal ST depression in the lateral leads (I, aVL, V5\u2013V6), consistent with an anterior STEMI pattern known as \u201cprecordial swirl.\u201d There is also subtle ST elevation in lead III and aVF, which may reflect a wraparound LAD supplying part of the inferior wall. Despite the inferior changes, the overall pattern strongly suggests acute proximal LAD occlusion rather than RCA involvement. This is a cardiology emergency requiring urgent activation of the primary PCI pathway. \u00a9 Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg112.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Management of STEMI</h5><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd563b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd563.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd563b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the simplified management of STEMI according to NICE guidelines. A number of assumptions (listed at the bottom) are made.</div><br />Once a STEMI has been confirmed the first step is to immediately assess eligibility for coronary reperfusion therapy. There are two types of coronary reperfusion therapy:<br /><ul><li>percutaneous coronary intervention<ul><li>should be offered if the <span class=\"concept\" data-cid=\"11690\">presentation is within 12 hours of the onset of symptoms</span> AND <span class=\"concept\" data-cid=\"11117\">PCI can be delivered within 120 minutes of the time when fibrinolysis could have been given</span> (i.e. consider fibrinolysis if there is a significant delay in being able to provide PCI)</li><li>if patients present after 12 hours and still have evidence of ongoing ischaemia then PCI should still be considered</li><li><span class=\"concept\" data-cid=\"11119\">drug-eluting stents</span> are now used. Previously 'bare-metal' stents were sometimes used but have higher rates of restenosis</li><li><span class=\"concept\" data-cid=\"11118\">radial access is preferred to femoral access</span></li></ul></li><li>fibrinolysis<ul><li><span class=\"concept\" data-cid=\"11120\">should be offered within 12 hours of the onset of symptoms if primary PCI cannot be delivered within 120 minutes</span> of the time when fibrinolysis could have been given</li><li>a practical example may be a patient who presents with a STEMI to a small district general hospital (DGH) that does not have facilities for PCI. If they cannot be transferred to a larger hospital for PCI within 120 minutes then fibrinolysis should be given. If the patient's ECG taken 90 minutes after fibrinolysis failed to show resolution of the ST elevation then they would then require transfer for PCI</li></ul></li></ul><br />If patients are eligible this should be offered as soon as possible.<br /><br /><h6 class='notes-subheading'>Percutaneous coronary intervention for patients with STEMI</h6><br /><span class=\"concept\" data-cid=\"11125\">Further antiplatelet prior to PCI</span><br /><ul><li>this is termed 'dual antiplatelet therapy', i.e. aspirin + another drug</li><li>if the patient is not taking an oral anticoagulant: prasugrel</li><li>if taking an oral anticoagulant: clopidogrel</li></ul><br />Drug therapy during PCI<br /><ul><li>patients undergoing PCI with radial access:<ul><li><span class=\"concept\" data-cid=\"11126\">unfractionated heparin with bailout glycoprotein IIb/IIIa inhibitor (GPI)</span> - this is the action of using a GPI during the procedure when it was not intended from the outset, e.g. because of worsening or persistent thrombus</li></ul></li><li>patients undergoing PCI with femoral access:<ul><li>bivalirudin with bailout GPI</li></ul></li></ul><br />Other procedures during PCI<br /><ul><li>thrombus aspiration, but not mechanical thrombus extraction, should be considered</li><li>complete revascularisation should be considered for patients with multivessel coronary artery disease without cardiogenic shock</li></ul><br /><br /><h6 class='notes-subheading'>Fibrinolysis for patients with STEMI</h6><br />Fibrinolysis used to be the only form of coronary reperfusion therapy available. However, it is used much less commonly now given the widespread availability of PCI.<br /><br />The contraindications to fibrinolysis and other factors are described in other notes.<br /><br /><span class=\"concept\" data-cid=\"11127\">Patients undergoing fibrinolysis should also be given an antithrombin drug.</span><br /><br />An ECG should be repeated after <span class=\"concept\" data-cid=\"11249\">60-90 minutes</span> to see if the ECG changes have resolved. If patients have <span class=\"concept\" data-cid=\"11128\">persistent myocardial ischaemia following fibrinolysis then PCI should be considered</span>.<br /><br /><br /><h5 class='notes-heading'>Management of NSTEMI/unstable angina</h5><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd564b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd564.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd564b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the simplified management of NSTEMI/unstable angina according to NICE guidelines. A number of assumptions (listed at the bottom) are made.</div><br />The management of NSTEMI/unstable angina is complicated and depends on individual patient factors and a <span class=\"concept\" data-cid=\"11130\">risk assessment</span>. The summary below provides an overview but the full NICE guidelines should be reviewed for further details.<br /><br />Further drug therapy<br /><ul><li>antithrombin treatment<ul><li><span class=\"concept\" data-cid=\"11129\">fondaparinux</span> should be offered to patients who are not at a high risk of bleeding and who are not having angiography immediately</li><li>if immediate angiography is planned or a patients creatinine is > 265 \u00b5mol/L then unfractionated heparin should be given</li></ul></li></ul><br /><h6 class='notes-subheading'>Risk assessment</h6><br />The Global Registry of Acute Coronary Events (GRACE) is the most widely used tool for risk assessment. It can be calculated using online tools and takes into account the following factors:<br /><ul><li>age</li><li>heart rate, blood pressure</li><li>cardiac (Killip class) and renal function (serum creatinine)</li><li>cardiac arrest on presentation</li><li>ECG findings</li><li>troponin levels</li></ul><br />This results in the patient being risk stratified as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Predicted 6-month mortality</th><th>Risk of future adverse cardiovascular events</th></tr></thead><tbody><tr><td>1.5% or below</td><td>Lowest</td></tr><tr><td>> 1.5% to 3.0%</td><td>Low</td></tr><tr><td>> 3.0% to 6.0%</td><td>Intermediate</td></tr><tr><td>> 6.0% to 9.0%</td><td>High</td></tr><tr><td>over 9.0%</td><td>Highest</td></tr></tbody></table></div><br />Based on this <span class=\"concept\" data-cid=\"11130\">risk assessment key decisions are made</span> regarding whether a patient has coronary angiography (with follow-on PCI if necessary) or has conservative management. The detailed pros/cons of this decision are covered in other notes.<br /><br />Which patients with NSTEMI/unstable angina should have coronary angiography (with follow-on PCI if necessary)?<br /><ul><li><span class=\"concept\" data-cid=\"11131\">immediate: patient who are clinically unstable (e.g. hypotensive)</span></li><li><span class=\"concept\" data-cid=\"11132\">within 72 hours: patients with a GRACE score > 3%</span> i.e. those at intermediate, high or highest risk</li><li>coronary angiography should also be considered for patients if ischaemia is subsequently experienced after admission</li></ul><br /><h6 class='notes-subheading'>Percutaneous coronary intervention for patients with NSTEMI/unstable angina</h6><br /><span class=\"concept\" data-cid=\"11134\">Further drug therapy</span><br /><ul><li>unfractionated heparin should be given regardless of whether the patient has had fondaparinux or not</li><li>further antiplatelet ('dual antiplatelet therapy', i.e. aspirin + another drug) prior to PCI<ul><li>if the patient is not taking an oral anticoagulant: prasugrel or ticagrelor</li><li>if taking an oral anticoagulant: clopidogrel</li></ul></li></ul><br /><h6 class='notes-subheading'>Conservative management for patients with NSTEMI/unstable angina</h6><br /><span class=\"concept\" data-cid=\"11133\">Further drug therapy</span><br /><ul><li>further antiplatelet ('dual antiplatelet therapy', i.e. aspirin + another drug)<ul><li>if the patient is not at a high risk of bleeding: ticagrelor</li><li>if the patient is at a high risk of bleeding:  clopidogrel</li></ul></li></ul>",
        "notes_hash": "ea9781f6c3c89db8ba42d84c6765140e",
        "knowledge_graph_node_id_link": 1025,
        "concept": "ACS: Nitrates are contraindicated in patients with hypotension (< 90 mmHg)",
        "concept_percentile": "70",
        "concept_colour": "rgb(152,255,0)",
        "number_attempts": "6066",
        "up_votes": "17",
        "down_votes": "7",
        "column_array": [
            0,
            "63",
            "93",
            "376",
            "4635",
            "899",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>SIGN</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2001\" data-linkid=\"2001\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2001\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">32</span><button type=\"button\" style=\"\" id=\"link_dislike_2001\" data-linkid=\"2001\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2001\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">32</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.sign.ac.uk/assets/sign148.pdf\">2016 Acute coronary syndrome guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2000\" data-linkid=\"2000\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2000\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">65</span><button type=\"button\" style=\"\" id=\"link_dislike_2000\" data-linkid=\"2000\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2000\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">34</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng185\">2020 Acute coronary syndromes guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/TBG9Jw3yd9I\" data-description=\"Acute Coronary Syndrome DETAILED Overview (MI, STEMI, NSTEMI)\" data-upvotes=\"16\" data-downvotes=\"3\" data-media=\"418\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/TBG9Jw3yd9I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/TBG9Jw3yd9I\" data-description=\"Acute Coronary Syndrome DETAILED Overview (MI, STEMI, NSTEMI)\" data-upvotes=\"16\" data-downvotes=\"3\" data-media=\"418\">Acute Coronary Syndrome DETAILED Overview (MI, STEMI, NSTEMI)</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2033\" data-mediaid=\"2033\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2033\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"media_dislike_2033\" data-mediaid=\"2033\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2033\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eZBtQ0rDnG4\" data-description=\"Antiplatelets and anticoagulants made easy\" data-upvotes=\"9\" data-downvotes=\"4\" data-media=\"729\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/eZBtQ0rDnG4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eZBtQ0rDnG4\" data-description=\"Antiplatelets and anticoagulants made easy\" data-upvotes=\"9\" data-downvotes=\"4\" data-media=\"729\">Antiplatelets and anticoagulants made easy</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2034\" data-mediaid=\"2034\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2034\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_2034\" data-mediaid=\"2034\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2034\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "11117": {
                "concept_text": "STEMI management: PCI if presents within 12 hours of onset AND PCI can be delivered within 120 minutes of the time when fibrinolysis could have been given",
                "concept_percentile": "47"
            },
            "11120": {
                "concept_text": "STEMI management: fibrinolysis should be offered within 12 hours of onset of symptoms if primary PCI cannot be delivered within 120 minutes",
                "concept_percentile": "92"
            },
            "11121": {
                "concept_text": "All patients with suspect ACS should be given aspirin 300mg, but further drug management depends on the type of ACS, proposed intervention etc",
                "concept_percentile": "47"
            },
            "11122": {
                "concept_text": "ACS management: oxygen should only be given if the patient has oxygen saturations < 94%",
                "concept_percentile": "49"
            },
            "11125": {
                "concept_text": "STEMI management: if patient is having PCI then prasugrel is given in addition to aspirin. If patient is on an anticoagulant then clopidogrel used instead",
                "concept_percentile": "21"
            },
            "11126": {
                "concept_text": "STEMI management: for patients undergoing PCI, following dual antiplatelet therapy, patients are also given unfractionated heparin with bailout glycoprotein IIb/IIIa inhibitor (GPI) if radial access used",
                "concept_percentile": "13"
            },
            "11127": {
                "concept_text": "Patients undergoing fibrinolysis for a STEMI should also be given an antithrombin drug",
                "concept_percentile": "53"
            },
            "11129": {
                "concept_text": "NSTEMI management: fondaparinux should be given in addition to aspirin to all patients unless high bleeding risk",
                "concept_percentile": "38"
            },
            "11130": {
                "concept_text": "NSTEMI management is determined by a risk assessment score such as GRACE",
                "concept_percentile": "43"
            },
            "11132": {
                "concept_text": "NSTEMI management: patients with a GRACE score > 3% should have coronary angiography within 72 hours of admission",
                "concept_percentile": "37"
            },
            "11133": {
                "concept_text": "NSTEMI (managed conservatively) antiplatelet choice\n   - aspirin, plus either:\n   - ticagrelor, if not high bleeding risk\n   - clopidogrel, if high bleeding risk",
                "concept_percentile": "80"
            },
            "11134": {
                "concept_text": "NSTEMI (managed with PCI) antiplatelet choice:\n   - if the patient is not taking an oral anticoagulant: prasugrel or ticagrelor\n   - if taking an oral anticoagulant: clopidogrel",
                "concept_percentile": "24"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16718_B_189",
        "new_question_id": "30642",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "11264",
        "notes_id_link": "1_213",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "<i>Campylobacter jejuni</i>",
            "<i>Escherichia coli</i>",
            "Coxsackievirus",
            "Herpes simplex virus",
            "Varicella-zoster virus",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 47-year-old male presents to the emergency department with weakness in both legs that is progressing upwards. It started one week ago with some leg pain that later developed into weakness. On examination, there is a bilateral reduction in patellar reflex, strength throughout the neurological examination in the lower limbs bilaterally is 3/5 and sensation is normal. He has no relevant past medical history and takes no regular medications. <br /><br />Which one of the following organisms is most likely to have caused his symptoms?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is <i>Campylobacter jejuni</i>. The patient presents with the typical symptoms of Guillain-Barre syndrome: progressive, symmetrical weakness of the limbs, often in an ascending fashion. This is immune-mediated demyelination of the peripheral nervous system often triggered by an infection, classically caused by <i>Campylobacter jejuni</i>. Around 65% of patients experience leg or back pain prior to the development of weakness, consistent with the patient in this vignette. The ascending weakness of the legs, in conjunction with the diminished reflexes and normal sensation, is typical of the disease. <br /><br /><i>Escherichia coli</i> is the most common cause of traveller's diarrhoea and gastroenteritis. It has no role in the development of Guillain-Barre syndrome. <br /><br />Coxsackievirus is the most common cause of viral meningitis in adults but has no link with Guillain-Barre syndrome. <br /><br />Herpes simplex virus causes genital and labial sores. It has no role in the development of this disease. <br /><br />Varicella-zoster virus causes chickenpox and shingles. It has not been found to be connected with Guillain-Barre syndrome.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 47-year-old male presents to the emergency department with weakness in both legs that is progressing upwards. It started one week ago with some leg pain that later developed into weakness. On examination, there is a bilateral reduction in patellar reflex, strength throughout the neurological examination in the lower limbs bilaterally is 3/5 and sensation is normal. He has no relevant past medical history and takes no regular medications. <br /><br />Which one of the following organisms is most likely to have caused his symptoms?",
        "correct_answer": "1",
        "question_notes": "The correct answer is <i>Campylobacter jejuni</i>. The patient presents with the typical symptoms of Guillain-Barre syndrome: progressive, symmetrical weakness of the limbs, often in an ascending fashion. This is immune-mediated demyelination of the peripheral nervous system often triggered by an infection, classically caused by <i>Campylobacter jejuni</i>. Around 65% of patients experience leg or back pain prior to the development of weakness, consistent with the patient in this vignette. The ascending weakness of the legs, in conjunction with the diminished reflexes and normal sensation, is typical of the disease. <br /><br /><i>Escherichia coli</i> is the most common cause of traveller's diarrhoea and gastroenteritis. It has no role in the development of Guillain-Barre syndrome. <br /><br />Coxsackievirus is the most common cause of viral meningitis in adults but has no link with Guillain-Barre syndrome. <br /><br />Herpes simplex virus causes genital and labial sores. It has no role in the development of this disease. <br /><br />Varicella-zoster virus causes chickenpox and shingles. It has not been found to be connected with Guillain-Barre syndrome.",
        "answer_order": "1",
        "answer": "1",
        "title": "Guillain-Barre syndrome",
        "body": "Guillain-Barre syndrome describes an immune-mediated demyelination of the peripheral nervous system often triggered by an infection (classically <span class=\"concept\" data-cid=\"11264\"><i>Campylobacter jejuni</i></span>)<br /><br />Pathogenesis<br /><ul><li>cross-reaction of antibodies with gangliosides in the peripheral nervous system</li><li>correlation between anti-ganglioside antibody (e.g. anti-GM1) and clinical features has been demonstrated</li><li>anti-GM1 antibodies in 25% of patients</li></ul><br />Miller Fisher syndrome<br /><ul><li>variant of Guillain-Barre syndrome</li><li>associated with ophthalmoplegia, areflexia and ataxia. The eye muscles are typically affected first</li><li>usually presents as a descending paralysis rather than ascending as seen in other forms of Guillain-Barre syndrome</li><li>anti-GQ1b antibodies are present in 90% of cases</li></ul>",
        "notes_hash": "1901576793752d5bbbbef27c70478c1e",
        "knowledge_graph_node_id_link": 1142,
        "concept": "Guillain-Barre syndrome is classically triggered by  <i>Campylobacter jejuni</i> infection",
        "concept_percentile": "56",
        "concept_colour": "rgb(224,255,0)",
        "number_attempts": "6371",
        "up_votes": "30",
        "down_votes": "7",
        "column_array": [
            0,
            "5317",
            "398",
            "334",
            "174",
            "148",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Medcomic</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2058\" data-linkid=\"2058\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2058\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">23</span><button type=\"button\" style=\"\" id=\"link_dislike_2058\" data-linkid=\"2058\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2058\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.medcomic.com/medcomic/guillain-barre-syndrome\">Guillain-Barre syndrome</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/7vmZVNmAYf4\" data-description=\"Guillain-Barre Syndrome (GBS) (Described Concisely)\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"536\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/7vmZVNmAYf4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/7vmZVNmAYf4\" data-description=\"Guillain-Barre Syndrome (GBS) (Described Concisely)\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"536\">Guillain-Barre Syndrome (GBS) (Described Concisely)</a></td></tr><tr><td><span ><small>PhysioPathoPharmaco - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_918\" data-mediaid=\"918\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_918\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_918\" data-mediaid=\"918\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_918\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_18qcTtUuyA\" data-description=\"Guillain-Barre syndrome\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"699\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/_18qcTtUuyA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_18qcTtUuyA\" data-description=\"Guillain-Barre syndrome\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"699\">Guillain-Barre syndrome</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1215\" data-mediaid=\"1215\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1215\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_1215\" data-mediaid=\"1215\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1215\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/KUEunZYZgII\" data-description=\"Understanding Guillain-Barre Syndrome\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1213\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/KUEunZYZgII/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/KUEunZYZgII\" data-description=\"Understanding Guillain-Barre Syndrome\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1213\">Understanding Guillain-Barre Syndrome</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2126\" data-mediaid=\"2126\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2126\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2126\" data-mediaid=\"2126\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2126\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "11264": {
                "concept_text": "Guillain-Barre syndrome is classically triggered by  <i>Campylobacter jejuni</i> infection",
                "concept_percentile": "56"
            }
        },
        "optimisation_reason": ""
    }
]